According to the latest issue of the journal, Multidrug Resistant-Tuberculosis (MDR-TB), a version of the disease where patients do not respond to first-line drugs, will become more common than it is now. The report projects that, by 2040, the percentage of MDR-TB will make up 32.5% of all TB cases in Russia, 12.4% of the TB cases in India, 8.9% of the TB cases in the Philippines, and 5.7% of all TB cases in South Africa. Not only does India shoulder the highest TB burden in the world, with over 2 million of the 10 million reported cases, it also accounts for the most drug-resistant patients — nearly 1.3 lakh people who do not respond to first-line drugs.
— source thehindu.com